siRNA therapy decreases triglycerides in people along with unusual disorder

.RESEARCH STUDY EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% and also lowered the threat of pancreatitis in individuals along with persistent chylomicronemia, with or without a genetic medical diagnosis.